Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid vs SMOFlipid in Premature Newborns
NCT03857646Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Mar 2019
- Primary completion
- Jun 2020
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of SMOFlipid in Prematurity (PTB) (2 arms), sponsored by UTHealth Houston. Primary endpoint: Free Bilirubin at 2 days. Started Mar 2019; status: completed.
02
Drugs
SMOFlipid
03
Conditions
Prematurity (PTB)
Beyond the preview
Go deeper on NCT03857646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03857646.